A detailed history of Cornerstone Planning Group LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Cornerstone Planning Group LLC holds 13 shares of SRPT stock, worth $1,565. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13
Previous 28 53.57%
Holding current value
$1,565
Previous $3.94 Million 57.02%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$124.33 - $156.75 $1,864 - $2,351
-15 Reduced 53.57%
13 $1.69 Million
Q2 2024

Aug 13, 2024

BUY
$113.33 - $163.85 $3,173 - $4,587
28 New
28 $3.94 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.5B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Cornerstone Planning Group LLC Portfolio

Follow Cornerstone Planning Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Planning Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Planning Group LLC with notifications on news.